STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
46 hedge funds and large institutions have $39.1M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1M | |
| 2 | +$940K | |
| 3 | +$844K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$543K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$442K |
Top Sellers
| 1 | -$46.3M | |
| 2 | -$28.3M | |
| 3 | -$23M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$9.46M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.75M |